Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

UPDATE: GOP Rep. Chris Collins Resigns, Expected To Plead Guilty To Insider Trading


By

Jake Offenhartz

Published Sep 30, 2019


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .

Chris Collins seconds the nomination of Donald Trump as the GOP nominee for President of the United States

 

SHUTTERSTOCK


By

Jake Offenhartz

Published Sep 30, 2019


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

Representative Chris Collins, a Buffalo-area congressman and early Trump booster, is poised to plead guilty to insider trading charges. [UPDATE: Collins has reportedly resigned from his seat.]

The GOP lawmaker was charged last year with trading insider information related to Australian biotech company Innate Immunotherapeutics, on whose board he served. He was arrested along with his son Cameron Collins, as well as the father of Cameron's fiancée, Stephen Zarsky.

While Collins had initially entered a not-guilty plea—describing the charges as "meritless"—a new docket entry in the case shows that Collins intends to change his plea on Tuesday. His co-defendants will reverse their pleas on Thursday, records show.

According to the U.S. Attorney's Office, Collins was at a White House picnic in 2017 when he got inside information that the biotech company's sole drug had failed a clinical test. He passed that information to his son, who dumped his shares in the company and alerted Zarsky, prosecutors allege.

When news of the failed drug test was publicly released later that month, shares in the company dropped 92 percent.

Remarkably, the actual conversation appears to have been caught on video by CBS news (Jared Kushner also makes a cameo).

Collins was the first member of Congress to endorse Donald Trump's bid for president. He won a fourth term last year, following his indictment, but is reportedly bleeding full-time staffers. The congressman now faces eight counts of securities fraud, wire fraud, and making false statements.

A spokesperson for Collins did not respond to Gothamist's inquiries.

UPDATE: The Congressman has reportedly delivered his resignation letter to Speaker Nancy Pelosi. He plans to make it official on the house floor Tuesday morning. The seat will be filled following the results of a special election.

Tagged

insider trading

upstate new york

chris collins

trump

Congress


Jake Offenhartz

Jake Offenhartz is a former Gothamist reporter.

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

Have you seen this Yorkie? NYPD looking for adorable pup dognapped from her Queens home

Suspects were driving a Subaru Forester, police said.

By

Ryan Kost

Published Oct 17, 2026 at 11:36 a.m. ET


Being reigning champions is weird for Knicks fans, but we could get used to this.

Seeing high hopes dashed had become so routine, it was part of our identity. This year feels different.

By

Catalina Gonella

News

Being reigning champions is weird for Knicks fans, but we could get used to this.

Seeing high hopes dashed had become so routine, it was part of our identity. This year feels different.

By

Catalina Gonella


Tompkins Square Park is getting a makeover. Some say it's too much.

By

Willow Higgins

Deer are all over New Jersey roads looking for sex, state officials warn

By

Rosemary Misdary

Man messaged 'I got straight poison' before giving NYC college students fentanyl, feds say

By

Samantha Max


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .